CorMatrix Cardiovascular Inc. announced treatment of the first patient to receive their tissue-engineered regenerative CorMatrix ECM (Extracellular Matrix) Tricuspid Valve. The operation was performed by Marc Gerdisch, M.D., FACS, FACC, chief of cardiovascular and thoracic surgery at Franciscan St. Francis Health in Indianapolis.

A surgical team at Baylor University Medical Center at Dallas successfully performed a heart transplant on a patient they were keeping alive with a total artificial heart.

Nearly half of all atrial fibrillation (AF) patients at the highest risk for stroke are not being prescribed blood thinners by their cardiologists, according to a new study.

Medtronic plc announced that it received CE (Conformité Européenne) Mark for the first and only cardiac resynchronization therapy defibrillators (CRT-Ds) approved for 3 Tesla (T) magnetic resonance imaging (MRI) scans.

Boston Scientific announced in late February that the Eluvia Drug-Eluting Vascular Stent System received CE Mark, and is commencing commercialization immediately in the European Union and other countries where CE Mark is recognized.

Clarius Mobile Health is showcasing a new handheld ultrasound scanner with a mobile application for iOS and Android smart devices at the American Institute of Ultrasound in Medicine Conference in New York, March 18-21.

A recent study is bringing new hope to families of children who struggle with a common form of leukemia and thus must confront an elevated risk for long-term heart ailments caused by chemotherapy.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now